Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Market Analysis & Valuation

UpdatedSep 19, 2025
DataAggregated Company Financials
Companies136
  • 7D4.7%
  • 3M-9.5%
  • 1Y-37.3%
  • YTD-21.9%

Over the last 7 days, the market has risen 4.7%, driven by gains of 10% in the Healthcare sector. In contrast, the Utilities sector is lagging, dropping 48%. Longer term the market is actually down 37% over the past year. Earnings are forecast to grow by 3.8% annually.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Danish Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 19 Sep 2025DKK 4.1tDKK 1.9tDKK 287.0b15.3x14.5x2.2x
Sun, 17 Aug 2025DKK 3.9tDKK 1.9tDKK 280.3b14.8x13.8x2x
Tue, 15 Jul 2025DKK 4.4tDKK 1.9tDKK 262.0b15.8x16.8x2.4x
Thu, 12 Jun 2025DKK 4.8tDKK 1.9tDKK 263.0b15.8x18.4x2.6x
Sat, 10 May 2025DKK 4.4tDKK 1.9tDKK 266.9b15.1x16.3x2.3x
Mon, 07 Apr 2025DKK 4.1tDKK 1.9tDKK 260.3b13x15.8x2.2x
Wed, 05 Mar 2025DKK 5.3tDKK 1.9tDKK 263.2b13.8x20x2.8x
Fri, 31 Jan 2025DKK 5.2tDKK 1.8tDKK 238.1b14.1x21.7x2.8x
Sun, 29 Dec 2024DKK 5.3tDKK 1.8tDKK 238.2b13.9x22.4x2.9x
Tue, 26 Nov 2024DKK 5.8tDKK 1.8tDKK 237.6b14.6x24.5x3.2x
Thu, 24 Oct 2024DKK 6.1tDKK 1.7tDKK 180.2b15.2x33.7x3.5x
Sat, 21 Sep 2024DKK 6.4tDKK 1.7tDKK 180.0b16.1x35.5x3.7x
Mon, 19 Aug 2024DKK 6.6tDKK 1.7tDKK 180.2b16.8x36.8x3.8x
Wed, 17 Jul 2024DKK 6.8tDKK 1.7tDKK 185.3b15.6x36.9x4x
Fri, 14 Jun 2024DKK 7.0tDKK 1.7tDKK 184.7b15.5x37.7x4.1x
Sun, 12 May 2024DKK 6.5tDKK 1.7tDKK 183.8b14.7x35.1x3.8x
Tue, 09 Apr 2024DKK 6.4tDKK 1.7tDKK 192.3b15x33.2x3.7x
Thu, 07 Mar 2024DKK 6.3tDKK 1.7tDKK 191.8b13.2x32.7x3.7x
Sat, 03 Feb 2024DKK 6.0tDKK 1.8tDKK 225.0b14.1x26.5x3.3x
Mon, 01 Jan 2024DKK 5.5tDKK 1.8tDKK 216.0b14.2x25.7x3.1x
Wed, 29 Nov 2023DKK 5.3tDKK 1.8tDKK 216.1b13.2x24.7x3x
Fri, 27 Oct 2023DKK 5.2tDKK 1.9tDKK 284.4b12.4x18.3x2.8x
Sun, 24 Sep 2023DKK 5.3tDKK 1.9tDKK 283.7b13.1x18.6x2.8x
Tue, 22 Aug 2023DKK 5.3tDKK 1.9tDKK 281.2b13.3x18.7x2.8x
Thu, 20 Jul 2023DKK 5.0tDKK 1.9tDKK 318.4b13.4x15.8x2.6x
Sat, 17 Jun 2023DKK 5.2tDKK 1.9tDKK 322.1b13.8x16x2.7x
Mon, 15 May 2023DKK 5.3tDKK 1.9tDKK 322.8b14.2x16.5x2.8x
Wed, 12 Apr 2023DKK 4.9tDKK 1.9tDKK 343.9b15x14.2x2.6x
Fri, 10 Mar 2023DKK 4.8tDKK 1.9tDKK 348.8b14.2x13.8x2.5x
Sun, 05 Feb 2023DKK 4.7tDKK 1.9tDKK 356.0b14.1x13.2x2.5x
Tue, 03 Jan 2023DKK 4.6tDKK 1.9tDKK 359.2b13.6x12.9x2.4x
Thu, 01 Dec 2022DKK 4.5tDKK 1.9tDKK 366.5b14x12.2x2.3x
Sat, 29 Oct 2022DKK 4.3tDKK 1.9tDKK 328.1b13.5x13.1x2.2x
Mon, 26 Sep 2022DKK 4.0tDKK 1.9tDKK 349.4b12.4x11.5x2.1x
Price to Earnings Ratio

11.5x


Total Market Cap: DKK 4.0tTotal Earnings: DKK 349.4bTotal Revenue: DKK 1.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Market Price to Earnings3Y Average 21.9x202320242025
Current Market PE
  • Investors are pessimistic on the Danish market, indicating that they anticipate earnings will not grow as fast as they have historically.
  • The market is trading at a PE ratio of 14.5x which is lower than its 3-year average PE of 21.9x.
Past Earnings Growth
  • The earnings for Danish listed companies have declined 6.3% per year over the last three years.
  • Meanwhile revenues have been flat.
  • This means that either the cost of doing business or the level of investment back into businesses is increasing since sales have remained steady while profits have fallen.

Sector Trends

Which sectors have driven the changes within the Danish Market?

DK Market4.67%
Healthcare10.18%
Energy4.83%
Telecom2.57%
Industrials2.21%
Consumer Discretionary1.67%
Tech1.59%
Financials0.87%
Real Estate-1.08%
Materials-1.64%
Consumer Staples-2.01%
Utilities-48.12%
Sector PE
  • Investors favour the Materials sector the most for future growth even though it's trading below its 3-year average PE ratio of 54.6x.
    • Analysts are expecting annual earnings growth of 17.7%, which is lower than the prior year's growth of 99.4% per year.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 29% over the next 5 years.
  • This is better than its past earnings growth rate of 9.2% per year.
  • In contrast, the Energy sector is expected to see its earnings decline by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
NOVO B Novo NordiskDKK 388.6011.6%
+DKK 179.1b		-54.3%PE15.5xHealthcare
MAERSK B A.P. Møller - MærskDKK 13.82k4.0%
+DKK 7.6b		28.6%PE4.8xIndustrials
DANSKE Danske BankDKK 269.101.7%
+DKK 3.7b		30.9%PB1.3xFinancials
ZEAL Zealand PharmaDKK 465.708.3%
+DKK 2.5b		-49.3%PE4.9xHealthcare
HLUN B H. LundbeckDKK 44.824.7%
+DKK 2.0b		-1.5%PE12.7xHealthcare
See more

Market Insights

Header cover image
🥇 Gold Breaks Records While Oil Sinks: Commodities 2025 in Contrast
Richard Bowman avatar
Richard Bowman
|
|
It’s been a while since we checked in on commodity markets, which, like other markets, are having quite the interesting year. In particular, gold continues its march upward, while oil remains in a slump. As for the rest, most have been up and down and ended up close to where they were a year ago. By the end, you’ll see why gold stocks still look cheap despite these record prices — and why oil stocks, oddly enough, look expensive even as crude declines.
Continue reading
🥇 Gold Breaks Records While Oil Sinks: Commodities 2025 in Contrast
Last Week

🥇 Gold Breaks Records While Oil Sinks: Commodities 2025 in Contrast

Latest News

NOVO B
DKK 388.60
Novo Nordisk
7D
11.6%
1Y
-54.3%
CHEMM
DKK 650.50
ChemoMetec
7D
20.0%
1Y
52.1%
ORSTED
DKK 105.35
Ørsted
7D
-47.4%
1Y
-75.8%
DEMANT
DKK 238.00
Demant
7D
-4.4%
1Y
-11.2%

Is There Now An Opportunity In Demant A/S (CPH:DEMANT)?

Sep 16
Is There Now An Opportunity In Demant A/S (CPH:DEMANT)?
EMBLA
DKK 31.60
Embla Medical hf
7D
8.6%
1Y
1.3%
GMAB
DKK 1,776.50
Genmab
7D
-2.5%
1Y
0.7%
ZEAL
DKK 465.70
Zealand Pharma
7D
8.3%
1Y
-49.3%

Clinical Catalysts And Roche Alliance Will Advance Obesity Amid Risks

Analysts maintain a positive long-term outlook on Zealand Pharma despite near-term competitive and pipeline risks, leading to a modest consensus price target reduction from DKK835.47 to DKK818.80 as updated risk assessments are incorporated. Analyst Commentary Bullish analysts cite attractive entry points at current share levels, suggesting the stock is undervalued given long-term growth potential.
HLUN B
DKK 44.82
H. Lundbeck
7D
4.7%
1Y
-1.5%

CNS Pipeline And Global Expansion Will Unlock Future Opportunities

With both future P/E and consensus revenue growth forecasts essentially unchanged, there has been no meaningful revision to H. Lundbeck's analyst price target, which remains at DKK48.18.
ALK B
DKK 211.00
ALK-Abelló
7D
2.3%
1Y
16.0%
CARL B
DKK 755.00
Carlsberg
7D
-1.9%
1Y
-2.3%

India And China Expansion Will Unlock Premium Market Potential

With both consensus revenue growth (7.2% p.a.) and net profit margin (9.97%) forecasts unchanged, analysts have left Carlsberg’s fair value estimate steady at DKK972.95. Valuation Changes Summary of Valuation Changes for Carlsberg The Consensus Analyst Price Target remained effectively unchanged, at DKK972.95.
DSV
DKK 1,320.50
DSV
7D
-3.2%
1Y
-3.2%

Schenker Integration Will Streamline Global Logistics And Digital Systems

Analysts maintain an Overweight rating on DSV but have adopted short-term caution due to integration uncertainties following the Schenker acquisition, anticipating a nuanced Q2 and modestly reducing the price target to DKK1779. Analyst Commentary JPMorgan reduces price target in anticipation of a "nuanced quarter" due to the first-time consolidation of Schenker following the recent acquisition.
MAERSK B
DKK 13,815.00
A.P. Møller - Mærsk
7D
4.0%
1Y
28.6%

China's Export Share Decline Will Drag Down Shipping Volumes

A.P. Møller - Mærsk’s consensus price target was modestly lowered to DKK11,762 as analysts remain cautious due to persistent container shipping demand softness, ongoing supply/demand imbalances, and constrained pricing power, despite some resilience in logistics and improving spot rates. Analyst Commentary Mixed outlook on global shipping rates, with weak performance in February and March offset by strength in June, leading to selective upward price target adjustments focused on Q3 recovery.
NSIS B
DKK 392.10
Novozymes
7D
-2.2%
1Y
-14.6%
COLO B
DKK 595.20
Coloplast
7D
-3.4%
1Y
-33.9%

Chronic Care Focus And Emerging Markets Will Redefine Healthcare

Coloplast’s consensus price target was modestly reduced to DKK718.06 as analysts weighed concerns about slowing revenue growth and margin pressure against stable demand in key product portfolios and longer-term benefits from innovation and expansion. Analyst Commentary Bearish analysts cite concerns over slowing revenue growth and margin pressure, particularly in core European markets.
DANSKE
DKK 269.10
Danske Bank
7D
1.7%
1Y
30.9%

Intensified Digital Competition And EU Regulations Will Depress Valuations

The modest increase in Danske Bank’s consensus price target reflects a higher anticipated future P/E multiple, with fair value now at DKK278.21. What's in the News Completed share buyback of 7,800,000 shares (0.94%) for DKK 1,800 million.
TRYG
DKK 164.30
Tryg
7D
-1.9%
1Y
4.6%